{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:34:35Z","timestamp":1792931675649,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["21819"],"award-info":[{"award-number":["21819"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coordination for Improvement of Higher Education Personnel\u2013Brazil"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23MH91182-1A1"],"award-info":[{"award-number":["1K23MH91182-1A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["PPRN-1306-04925, PPRND-1507-31449, XPPRN-1512-33786"],"award-info":[{"award-number":["PPRN-1306-04925, PPRND-1507-31449, XPPRN-1512-33786"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","award":["SRG-0-090-11"],"award-info":[{"award-number":["SRG-0-090-11"]}],"id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda","award":["TAK-375SL_201"],"award-info":[{"award-number":["TAK-375SL_201"]}]},{"name":"Takeda\/Lundbeck"},{"name":"AlfaSigma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.biopsych.2017.12.014","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T03:07:54Z","timestamp":1515553674000},"page":"761-769","source":"Crossref","is-referenced-by-count":94,"title":["Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders"],"prefix":"10.1016","volume":"83","author":[{"given":"Andrew A.","family":"Nierenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmin A.","family":"Ghaznavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora","family":"Sande Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen K.","family":"Ellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Janos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa G.","family":"Sylvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2017.12.014_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2017.12.014_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2014.06.005","article-title":"Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation","volume":"54","author":"Sharma","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpsychires.2017.03.025","article-title":"Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study\u2014Metabolic syndrome in current depressive episode","volume":"92","author":"Moreira","year":"2017","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2017.12.014_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/eurpub\/ckv245","article-title":"Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987\u20132010","volume":"26","author":"Osby","year":"2016","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.biopsych.2017.12.014_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jad.2016.03.004","article-title":"Exercise in bipolar patients: A systematic review","volume":"198","author":"Melo","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2017.12.014_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jad.2013.07.031","article-title":"Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder","volume":"151","author":"Sylvia","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2017.12.014_bib7","doi-asserted-by":"crossref","first-page":"658520","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.biopsych.2017.12.014_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tem.2012.06.006","article-title":"Transcriptional integration of mitochondrial biogenesis","volume":"23","author":"Scarpulla","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.bbalip.2016.09.003","article-title":"The effect of regulating molecules on the structure of the PPAR\u2013RXR complex","volume":"1861","author":"Amber-Vitos","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2017.12.014_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature07206","article-title":"The role of exercise and PGC1\u03b1 in inflammation and chronic disease","volume":"454","author":"Handschin","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.12.014_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1\u03b1 null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2017.12.014_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cmet.2012.08.012","article-title":"Energy intake and exercise as determinants of brain health and vulnerability to injury and disease","volume":"16","author":"Mattson","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1073\/pnas.1321881111","article-title":"Mitochondria impact brain function and cognition","volume":"111","author":"Picard","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.12.014_bib15","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.febslet.2010.06.035","article-title":"Brown vs white adipocytes: The PPARgamma coregulator story","volume":"584","author":"Koppen","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biopsych.2017.12.014_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/joim.12547","article-title":"Epigenomic and transcriptional control of insulin resistance","volume":"280","author":"Rosen","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1440-1681.2009.05275.x","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator-1alpha in muscle links metabolism to inflammation","volume":"36","author":"Handschin","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2012.06738.x","article-title":"Role of PGC-1\u03b1 signaling in skeletal muscle health and disease","volume":"1271","author":"Kang","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/brv.12099","article-title":"Molecular pathways linking non-shivering thermogenesis and obesity: Focusing on brown adipose tissue development","volume":"90","author":"Valente","year":"2015","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.1016\/j.biopsych.2017.12.014_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/dvdy.24538","article-title":"Mitochondrial dynamics in the regulation of neurogenesis: From development to the adult brain","volume":"247","author":"Khacho","year":"2018","journal-title":"Dev Dyn"},{"key":"10.1016\/j.biopsych.2017.12.014_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neubiorev.2004.03.002","article-title":"The selfish brain: Competition for energy resources","volume":"28","author":"Peters","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2017.12.014_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.1997.77.3.731","article-title":"Cellular energy utilization and molecular origin of standard metabolic rate in mammals","volume":"77","author":"Rolfe","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2017.12.014_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","article-title":"Synaptic energy use and supply","volume":"75","author":"Harris","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2017.12.014_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fnins.2017.00288","article-title":"How energy metabolism supports cerebral function: Insights from 13C magnetic resonance studies in\u00a0vivo","volume":"11","author":"Sonnay","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mito.2016.07.003","article-title":"The rise of mitochondria in medicine","volume":"30","author":"Picard","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopsych.2017.12.014_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2353\/ajpath.2010.081068","article-title":"Abnormalities in mitochondrial structure in cells from patients with bipolar disorder","volume":"177","author":"Cataldo","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.schres.2016.10.037","article-title":"Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond","volume":"187","author":"Kato","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2017.12.014_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: A mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pnpbp.2011.02.019","article-title":"(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pneurobio.2011.10.004","article-title":"PGC-1\u03b1 at the intersection of bioenergetics regulation and neuron function: From Huntington\u2019s disease to Parkinson\u2019s disease and beyond","volume":"97","author":"Tsunemi","year":"2012","journal-title":"Prog Neurobiol"},{"issue":"Pt 21","key":"10.1016\/j.biopsych.2017.12.014_bib32","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism\u2014Emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2017.12.014_bib34","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","article-title":"PGC-1\u03b1 and PGC-1\u03b2 regulate mitochondrial density in neurons","volume":"284","author":"Wareski","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.12.014_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4781(02)00343-3","article-title":"Nuclear activators and coactivators in mammalian mitochondrial biogenesis","volume":"1576","author":"Scarpulla","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2017.12.014_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2016.11.045","article-title":"Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance","volume":"102","author":"Raefsky","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/iub.1097","article-title":"Peroxisome proliferator-activated receptor-\u03b3 cofactors in neurodegeneration","volume":"64","author":"Katsouri","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopsych.2017.12.014_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-8993(02)03961-6","article-title":"Characterization of the peroxisome proliferator activated receptor coactivator 1 alpha (PGC 1alpha) expression in the murine brain","volume":"961","author":"Tritos","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2017.12.014_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2017.12.014_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fncel.2017.00030","article-title":"Molecular mechanisms of bipolar disorder: Progress made and future challenges","volume":"11","author":"Kim","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A\u00a0detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343966","article-title":"Role of inflammation in depression: Implications for phenomenology, pathophysiology and treatment","volume":"28","author":"Raison","year":"2013","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.69","article-title":"Inflammation and depression: A causal or coincidental link to the pathophysiology?","volume":"30","author":"Leonard","year":"2018","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.biopsych.2017.12.014_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004850-200607000-00004","article-title":"Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression","volume":"21","author":"Brunello","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","article-title":"Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study","volume":"21","author":"Mendlewicz","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib48","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2007.08205.x","article-title":"Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks","volume":"157","author":"Krishnan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib49","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1152\/ajpendo.00297.2015","article-title":"Revisiting the adipocyte: A model for integration of cytokine signaling in the regulation of energy metabolism","volume":"309","author":"Rodriguez","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib50","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbrc.2015.06.166","article-title":"The PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in\u00a0vivo","volume":"464","author":"Eisele","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2017.12.014_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00281-013-0406-4","article-title":"Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology","volume":"36","author":"Eisele","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib52","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1074\/jbc.M112.375253","article-title":"The peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1\/\u03b2 (PGC-1) coactivators repress the transcriptional activity of NF-\u03baB in skeletal muscle cells","volume":"288","author":"Eisele","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2017.12.014_bib53","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1152\/japplphysiol.00086.2011","article-title":"Resistance exercise enhances the molecular signaling of mitochondrial biogenesis induced by endurance exercise in human skeletal muscle","volume":"111","author":"Wang","year":"2011","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib54","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1249\/MSS.0b013e3181d2d21c","article-title":"Relative workload determines exercise-induced increases in PGC-1alpha mRNA","volume":"42","author":"Nordsborg","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.biopsych.2017.12.014_bib55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cmet.2015.08.001","article-title":"Detection and quantitation of circulating human irisin by tandem mass spectrometry","volume":"22","author":"Jedrychowski","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib56","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1113\/jphysiol.2013.265371","article-title":"Greek goddess or Greek myth: The effects of exercise on irisin\/FNDC5 in humans","volume":"591","author":"Atherton","year":"2013","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BPL-150019","article-title":"FNDC5\/irisin\u2014Their role in the nervous system and as a mediator for beneficial effects of exercise on the brain","volume":"1","author":"Wrann","year":"2015","journal-title":"Brain Plast"},{"key":"10.1016\/j.biopsych.2017.12.014_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","article-title":"Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway","volume":"18","author":"Wrann","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2017.12.014_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-015-8370-x","article-title":"Does PGC1\u03b1\/FNDC5\/BDNF elicit the beneficial effects of exercise on neurodegenerative disorders?","volume":"18","author":"Jodeiri Farshbaf","year":"2016","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2015.02.008","article-title":"Skeletal muscle as an endocrine organ: PGC-1\u03b1, myokines and exercise","volume":"80","author":"Schnyder","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.biopsych.2017.12.014_bib61","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/1389450111007011262","article-title":"The role of PGC-1\u03b1 in the pathogenesis of neurodegenerative disorders","volume":"11","author":"Rona-Voros","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.biopsych.2017.12.014_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1\u03b1, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib63","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.6407-11.2012","article-title":"PGC-1\u03b1 negatively regulates extrasynaptic NMDAR activity and excitotoxicity","volume":"32","author":"Puddifoot","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biocel.2017.03.008","article-title":"Ligands of peroxisome proliferator-activated receptor-alpha promote glutamate transporter-1 endocytosis in astrocytes","volume":"86","author":"Huang","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib65","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/hmg\/ddw095","article-title":"Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington\u2019s disease","volume":"25","author":"Chandra","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2017.12.014_bib66","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2017.12.014_bib67","doi-asserted-by":"crossref","first-page":"35899","DOI":"10.1074\/jbc.M112.366419","article-title":"The peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis","volume":"287","author":"Benedusi","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"Pt A","key":"10.1016\/j.biopsych.2017.12.014_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2016.11.001","article-title":"ALS-causing mutations differentially affect PGC-1\u03b1 expression and function in the brain vs. peripheral tissues","volume":"97","author":"Bayer","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2017.12.014_bib69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037885","article-title":"A\u00a0randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2017.12.014_bib71","doi-asserted-by":"crossref","first-page":"582075","DOI":"10.1155\/2012\/582075","article-title":"A\u00a0pilot trial of pioglitazone HCl and tretinoin in ALS: Cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression","volume":"2012","author":"Levine","year":"2012","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.biopsych.2017.12.014_bib72","doi-asserted-by":"crossref","first-page":"16025","DOI":"10.1038\/npjparkd.2016.25","article-title":"Parkinson\u2019s disease as a system-level disorder","volume":"2","author":"Caligiore","year":"2016","journal-title":"npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.biopsych.2017.12.014_bib73","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1038\/s41598-017-05334-9","article-title":"\u03b1Synuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson\u2019s disease","volume":"7","author":"Pozo Devoto","year":"2017","journal-title":"Sci Rep"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2017.12.014_bib74","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2017.12.014_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15384101.2016.1252881","article-title":"Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis","volume":"16","author":"Di Giacomo","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopsych.2017.12.014_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-016-0090-7","article-title":"Pioglitazone ameliorates the phenotype of a novel Parkinson\u2019s disease mouse model by reducing neuroinflammation","volume":"11","author":"Pinto","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2017.12.014_bib77","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuropharm.2015.11.020","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist is neuroprotective and stimulates PGC-1\u03b1 expression and CREB phosphorylation in human dopaminergic neurons","volume":"102","author":"Makela","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2017.12.014_bib78","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(15)00144-1","article-title":"Pioglitazone in early Parkinson's disease: A phase\u00a02, multicentre, double-blind, randomised trial","volume":"14","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib79","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.mehy.2015.07.011","article-title":"We need to move more: Neurobiological hypotheses of physical exercise as a treatment for Parkinson\u2019s disease","volume":"85","author":"Monteiro-Junior","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopsych.2017.12.014_bib80","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2017.12.014_bib81","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archpsyc.65.7.785","article-title":"Association study of Wnt signaling pathway genes in bipolar disorder","volume":"65","author":"Zandi","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib82","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/gbb.12306","article-title":"Circadian genes and lithium response in bipolar disorders: Associations with PPARGC1A (PGC-1\u03b1) and RORA","volume":"15","author":"Geoffroy","year":"2016","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2017.12.014_bib83","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-008-9056-8","article-title":"Neuronal peroxisome proliferator-activated receptor gamma signaling: Regulation by mood-stabilizer valproate","volume":"35","author":"Lan","year":"2008","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biopsych.2017.12.014_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ajp.2008.08081195","article-title":"Antidepressant response associated with pioglitazone: Support for an overlapping pathophysiology between major depression and metabolic syndrome","volume":"166","author":"Kemp","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.12.014_bib85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1100\/tsw.2010.32","article-title":"Rosiglitazone add-on in treatment of depressed patients with insulin resistance: A pilot study","volume":"10","author":"Rasgon","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.biopsych.2017.12.014_bib86","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","article-title":"Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity","volume":"136","author":"Kemp","year":"2012","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2017.12.014_bib87","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.psychres.2015.10.013","article-title":"Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response","volume":"230","author":"Lin","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2017.12.014_bib88","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.12.014_bib89","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2017.12.014_bib90","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-\u03b3 agonism as a modulator of mood: Proof-of-concept for pioglitazone in bipolar depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2017.12.014_bib91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/da.22340","article-title":"Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: A randomized, double-blind, placebo-controlled trial","volume":"32","author":"Zeinoddini","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2017.12.014_bib92","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2017.12.014_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2840-4-14","article-title":"Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: The bezafibrate lessons","volume":"4","author":"Tenenbaum","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.biopsych.2017.12.014_bib94","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bbadis.2017.05.019","article-title":"Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency","volume":"1863","author":"Grings","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2017.12.014_bib95","first-page":"127","article-title":"Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma","volume":"1","author":"Hsu","year":"2014","journal-title":"J\u00a0Hepatocell Carcinoma"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322318300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322318300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:05:06Z","timestamp":1589821506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322318300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0006322318300076"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.014","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}